| Literature DB >> 31596248 |
Wataru Mimura1, Manabu Akazawa1.
Abstract
BACKGROUND: Heparinoid is a medication prescribed in Japan for skin diseases, such as atopic dermatitis and dry skin. Heparinoid prescription has increased with instances of internet blogs recommending its use as a cosmetic.Entities:
Keywords: Google Trends; heparinoid; infodemiology; internet; moisturizer; time series analysis
Year: 2019 PMID: 31596248 PMCID: PMC6812878 DOI: 10.2196/13212
Source DB: PubMed Journal: JMIR Public Health Surveill ISSN: 2369-2960
Figure 1Study flowchart.
Patients’ baseline characteristics.
| Characteristics | Population A: patients prescribed heparinoid along with other medicines | Population B: patients prescribed only heparinoid | ||||||
|
| Total (N=704,585) | Men (n=327,694) | Women (n=376,891) | Total (N=155,733) | Men (n=70,819) | Women (n=84,914) | ||
|
|
|
|
|
|
| |||
|
| 0-19 | 396,761 (56.31) | 200,973 (61.33) | 195,788 (51.95) | 114,503 (73.53) | 57,572 (81.29) | 56,931 (67.05) | |
|
| 20-59 | 278,625 (39.54) | 111,891 (34.14) | 166,734 (44.24) | 36,421 (23.39) | 11,194 (15.81) | 25,227 (29.71) | |
|
| ≥60 | 29,199 (4.14) | 14,830 (4.53) | 14,369 (3.81) | 4809 (3.09) | 2053 (2.90) | 2756 (3.25) | |
|
|
|
|
|
|
|
| ||
|
| Xerosis cutis | 571,167 (81.06) | 264,301 (80.65) | 306,866 (81.42) | 117,450 (75.42) | 53,117 (75.00) | 64,333 (75.76) | |
|
| Dermatitis, unspecified | 301,528 (42.80) | 138,321 (42.21) | 163,207 (43.30) | 34,234 (21.98) | 15,539 (21.94) | 18,695 (22.02) | |
|
| Atopic dermatitis, unspecified | 196,975 (27.96) | 101,037 (30.91) | 95,938 (25.45) | 22,656 (14.55) | 11,191 (15.80) | 11,465 (13.50) | |
|
| Other atopic dermatitis | 60,584 (8.60) | 31,581 (9.64) | 29,003 (7.70) | 11,769 (7.58) | 6073 (8.58) | 5696 (6.71) | |
|
|
|
|
|
|
|
| ||
|
| Total, N | 3,350,692 | 1,680,423 | 1,670,269 | 289,361 | 132,850 | 156,511 | |
|
|
|
|
|
|
|
|
| |
|
|
| 0-19 | 2,182,796 (65.14) | 1,150,733 (68.48) | 1,032,063 (61.79) | 226,044 (78.12) | 113,415 (85.37) | 112,629 (71.96) |
|
|
| 20-59 | 1,069,036 (31.90) | 477,357 (28.41) | 591,679 (35.42) | 55,547 (19.20) | 16,219 (12.21) | 39,337 (25.13) |
|
|
| ≥60 | 98,860 (2.95) | 52,333 (3.11) | 46,527 (2.79) | 7770 (2.69) | 3225 (2.43) | 4545 (2.90) |
Figure 2Time series data of Google Trends and prescriptions. (a) Google Trends search volume with three search terms from October 2007 to September 2017; search volume is the ratio of searches on each topic to searches on all topics, from 0 to 100. (b) Number of heparinoid-only prescriptions per 100,000 members of the population from October 2007 to September 2017. (c) Number of heparinoid-only prescriptions for patients aged 20-59 years per 100,000 members of the population from October 2007 to September 2017.
ARIMAa model parameter and Q statisticsb.
| Time series | Model | AICc | Q statistic | |
| Google Trends “ | Seasonal ARIMA (5,1,4 and 0,1,1) (12) | 704 | 17.7 | .22 |
| Prescriptions (total) | Seasonal ARIMA (2,1,5 and 2,1,0) (12) | 823 | 19.4 | .19 |
| Prescriptions (patients aged 20-59 years) | Seasonal ARIMA (4,1,5 and 0,1,1) (12) | 567 | 23.3 | .055 |
aARIMA: autoregressive integrated moving average.
bQ statistics test for residual autocorrelation. The null hypothesis is that autocorrelation with 24 lags would be equal to zero.
cAIC: Akaike Information Criterion.
Cross-correlation between prescriptions and Google Trends for “” (Hirudoid).
| Prescriptions | Lag (months) | Correlation coefficient | |
| Total | 0 | .25 | .005 |
| Patients aged 20-59 years | –1 | .30 | .001 |